Gianferrari Giulia, Martinelli Ilaria, Simonini Cecilia, Zucchi Elisabetta, Fini Nicola, Carra Serena, Moglia Cristina, Mandrioli Jessica
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Department of Neurosciences, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Front Neurol. 2023 Jan 4;13:1052341. doi: 10.3389/fneur.2022.1052341. eCollection 2022.
With upcoming personalized approaches based on genetics, it is important to report new mutations in amyotrophic lateral sclerosis (ALS) genes in order to understand their pathogenicity and possible patient responses to specific therapies. mutations are the second most frequent genetic cause of ALS in European populations. Here, we describe two seemingly unrelated Italian patients with ALS carrying the same heterozygous c.400_402 deletion (p.Glu134del). Both patients had spinal onset in their lower limbs, progressive muscular weakness with respiratory involvement, and sparing bulbar function. In addition to the clinical picture, we discuss the possible pathogenic role of this unfamiliar mutation.
随着基于遗传学的个性化治疗方法的出现,报告肌萎缩侧索硬化症(ALS)基因中的新突变对于了解其致病性以及患者对特定疗法的可能反应至关重要。在欧洲人群中,突变是ALS第二常见的遗传病因。在此,我们描述了两名看似不相关的患有ALS的意大利患者,他们携带相同的杂合c.400_402缺失(p.Glu134del)。两名患者均以下肢脊髓起病,进行性肌肉无力并累及呼吸,且延髓功能未受累。除了临床表现外,我们还讨论了这种不常见突变可能的致病作用。